清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Association between intracervical Foley balloon and clinical chorioamnionitis among patients with group B streptococcus colonization undergoing induction with standardized labor management

医学 绒毛膜羊膜炎 B组 产科 随机对照试验 胎龄 外科 怀孕 生物 遗传学
作者
Kira A. Bromwich,Jennifer A. McCoy,Alison G. Cahill,Anthony Sciscione,Lisa D. Levine
出处
期刊:American Journal Of Obstetrics & Gynecology Mfm [Elsevier BV]
卷期号:5 (11): 101167-101167 被引量:2
标识
DOI:10.1016/j.ajogmf.2023.101167
摘要

BACKGROUND Intracervical Foley balloons are commonly used for cervical ripening, but there has been a historical concern regarding an increased risk of clinical chorioamnionitis with Foley balloon use in patients with group B streptococcus. OBJECTIVE This study aimed to determine whether intracervical Foley balloon use in patients with group B streptococcus is associated with an increased risk of clinical chorioamnionitis. STUDY DESIGN This was a secondary analysis of a randomized controlled trial Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial that compared cervical ripening agents within a standardized labor protocol. Foley balloon (alone, with oxytocin, or with misoprostol) was compared with misoprostol only to evaluate the primary outcome of clinical chorioamnionitis, defined based on the American College of Obstetricians and Gynecologists guidelines. Patients with a term, singleton pregnancy with intact membranes and an unfavorable cervix (Bishop score of ≤6 and dilation ≤2 cm) and a known group B streptococcus status were included. The secondary outcomes included a composite postpartum maternal infectious outcome consisting of any occurrence of endometritis, wound infection, postpartum urinary tract infection, or maternal sepsis; additional secondary outcomes included neonatal outcomes. Binomial regression with robust error variance was used to evaluate whether group B streptococcus status modified the relationship between Foley balloon use and clinical chorioamnionitis and to adjust for confounders. RESULTS A total of 491 patients were enrolled in the original trial. Of these patients, 467 had a known group B streptococcus status and underwent cervical ripening: 182 (39.0%) had group B streptococcus, and 285 (61.0%) did not have group B streptococcus. Moreover, 73.0% of patients received a Foley balloon, and 27.0% of patients did not receive a Foley balloon. There was no difference in the demographic or clinical characteristics between groups. The overall rate of clinical chorioamnionitis was 12.2%, with no difference between those with and without a Foley balloon (12.6% vs 11.1%, respectively; P=.66). Group B streptococcus status did not modify the association between Foley balloon use and clinical chorioamnionitis (relative risk, 0.93; 95% confidence interval, 0.50–1.72). This remained unchanged after adjusting for gestational age (adjusted relative risk, 0.87; 95% confidence interval, 0.45–1.67). Furthermore, other maternal and neonatal outcomes were similar between groups. CONCLUSION In this secondary analysis of a large randomized trial using a standardized labor protocol, there was no increased risk of infectious morbidity with Foley balloon use in patients overall and in patients with group B streptococcus. Our findings support that a Foley balloon can be safely used for cervical ripening in patients with group B streptococcus colonization. Intracervical Foley balloons are commonly used for cervical ripening, but there has been a historical concern regarding an increased risk of clinical chorioamnionitis with Foley balloon use in patients with group B streptococcus. This study aimed to determine whether intracervical Foley balloon use in patients with group B streptococcus is associated with an increased risk of clinical chorioamnionitis. This was a secondary analysis of a randomized controlled trial Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial that compared cervical ripening agents within a standardized labor protocol. Foley balloon (alone, with oxytocin, or with misoprostol) was compared with misoprostol only to evaluate the primary outcome of clinical chorioamnionitis, defined based on the American College of Obstetricians and Gynecologists guidelines. Patients with a term, singleton pregnancy with intact membranes and an unfavorable cervix (Bishop score of ≤6 and dilation ≤2 cm) and a known group B streptococcus status were included. The secondary outcomes included a composite postpartum maternal infectious outcome consisting of any occurrence of endometritis, wound infection, postpartum urinary tract infection, or maternal sepsis; additional secondary outcomes included neonatal outcomes. Binomial regression with robust error variance was used to evaluate whether group B streptococcus status modified the relationship between Foley balloon use and clinical chorioamnionitis and to adjust for confounders. A total of 491 patients were enrolled in the original trial. Of these patients, 467 had a known group B streptococcus status and underwent cervical ripening: 182 (39.0%) had group B streptococcus, and 285 (61.0%) did not have group B streptococcus. Moreover, 73.0% of patients received a Foley balloon, and 27.0% of patients did not receive a Foley balloon. There was no difference in the demographic or clinical characteristics between groups. The overall rate of clinical chorioamnionitis was 12.2%, with no difference between those with and without a Foley balloon (12.6% vs 11.1%, respectively; P=.66). Group B streptococcus status did not modify the association between Foley balloon use and clinical chorioamnionitis (relative risk, 0.93; 95% confidence interval, 0.50–1.72). This remained unchanged after adjusting for gestational age (adjusted relative risk, 0.87; 95% confidence interval, 0.45–1.67). Furthermore, other maternal and neonatal outcomes were similar between groups. In this secondary analysis of a large randomized trial using a standardized labor protocol, there was no increased risk of infectious morbidity with Foley balloon use in patients overall and in patients with group B streptococcus. Our findings support that a Foley balloon can be safely used for cervical ripening in patients with group B streptococcus colonization.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lovesxj941完成签到,获得积分10
刚刚
许若南完成签到 ,获得积分10
22秒前
听话的尔竹完成签到,获得积分10
40秒前
飞云完成签到 ,获得积分10
58秒前
害羞的雁易完成签到 ,获得积分10
58秒前
宏韬完成签到 ,获得积分10
1分钟前
阿俊1212完成签到 ,获得积分10
1分钟前
1分钟前
体贴的冷风完成签到 ,获得积分10
1分钟前
miaorunquan完成签到,获得积分0
1分钟前
1分钟前
1分钟前
1分钟前
2分钟前
qiqi完成签到 ,获得积分10
2分钟前
2分钟前
超级诗桃完成签到,获得积分10
2分钟前
如我所愿完成签到 ,获得积分10
2分钟前
阿连完成签到,获得积分10
2分钟前
YF是杨芳完成签到 ,获得积分10
2分钟前
Maestro_S的应助被东风采纳,获得10
2分钟前
可爱沛蓝完成签到 ,获得积分10
2分钟前
激动的元瑶完成签到 ,获得积分10
2分钟前
Maestro_S的应助被东风采纳,获得10
2分钟前
msn完成签到 ,获得积分10
2分钟前
夏日随笔完成签到 ,获得积分10
3分钟前
丰富的德天完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
仔仔完成签到 ,获得积分10
3分钟前
Wywy完成签到 ,获得积分10
3分钟前
薛定谔的猫完成签到 ,获得积分10
3分钟前
3分钟前
记上没文献了完成签到 ,获得积分10
3分钟前
3分钟前
4分钟前
林韵悠扬完成签到 ,获得积分10
4分钟前
CQNU破产之人完成签到 ,获得积分20
4分钟前
思源的应助被东风采纳,获得10
4分钟前
李爱国的应助被东风采纳,获得10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190312
求助须知:如何正确求助?哪些是违规求助? 9577402
关于积分的说明 21852440
捐赠科研通 7788867
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560109
邀请新用户注册赠送积分活动 2482945